A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

3K views

⸱

DOI:

10.3791/61503

⸱

September 22nd, 2020

 ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  , 

In This Article

Summary

Lower limb amputation may occur even after angioplasty of obstructed vessels in Critical Limb Ischemia (CLI). Mononuclear Progenitor Cells (MPCs) reflect vascular repair. The present protocol describes the quantification of MPCs from circulation close to angioplasty, and its relationship with endothelial dysfunction and prediction of lower limb amputation.

Abstract

Critical limb ischemia (CLI) represents an advanced stage of the peripheral arterial disease. Angioplasty improves the blood flow to the lower limb; however, some patients irreversibly progress to limb amputation. The extent of vascular damage and the mechanisms of vascular repair are factors affecting post-angioplasty outcome. Mononuclear Progenitor Cells (MPCs) are reactive to vascular damage and repair, with the ability to reflect vascular diseases. The present protocol describes quantification of MPCs obtained from blood circulation from vessel close to the angioplasty site, as well as its relationship with endothelial dysfunction and its predictive ability for limb amputation in the next 30 days after angioplasty in patients with CLI.

Introduction

Peripheral Arterial Disease (PAD) is characterized by a chronic and progressive vascular obstruction with limitation of blood supply1. At a global scale, PAD of the lower limbs affects around 10% of the elderly population, while up to 7% of such cases are submitted to limb amputation2,3.

Critical Limb Ischemia (CLI) represents the most serious presentation of PAD1. Patients usually experience pain at rest, ulcers, or gangrene attributable to occluded arteries; while clinical prognosis is unfavorable and marked by a 30% risk of limb amp....

Access restricted. Please log in or start a trial to view this content.

Protocol

The institutional research ethics committee from Centro Médico Nacional “20 de Noviembre” ISSSTE approved this prospective protocol, all enrolled patients provided written informed consent.

1. Evaluation of vascular block of lower limb, blood sampling and balloon angioplasty

NOTE: The study sample used for this experiment comprised of 20 diabetic patients, aged 68 years old and 10 out of 20 were males. Half of the sample were smokers and most prevalent co-morbidities were type 2 diabetes mellitus, systemic arterial hypertension and/or dyslipidemia. The sample was intended to be standardized for age....

Access restricted. Please log in or start a trial to view this content.

Results

Blood samples from blocked arteries, at the site addressed for angioplasty, were collected from 20 diabetic patients, aged 68 years old and 10 out of 20 were males. Half of sample population were smokers. Vascular lesions were mainly scored as Rutherford class VI; whereas patients showed a higher prevalence of type 2 Diabetes Mellitus (100%), hypertension (70%) and dyslipidemia (55%).

A 30 days clinical follow up after lower limb angioplasty was carried out. The percentage of MPC subpopulation.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Blood collection at the precise site of the vascular block may show technical difficulties; therefore, we performed blood collection in the proximity to vascular block. Likewise, the amount of MPCs close to the vascular plaque seems to be highly dynamic and may originate variations before and after angioplasty. According to our observations, it is recommended to evaluate baseline- and 30min-post-angioplasty changes in the number of MPCs, since they may reflect several pathophysiological processes occurring within vascula.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

The authors thank the support of Institutional Program E015 for the project ID 356.2015.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
BSARoche10735086001Bovine Serum Albumin (BSA) as a buffering agent, stabilizer, standard and for blending.
Calibration BeadsMiltenyi Biotec / MACS#130-093-607MACQuant calibration beads are supplied in aqueous solution containing 0.05% sodium azide. 3.5 ml for up to 100 tests
CD133/1 (AC133)-PEMilteny Biotec / MACS#130-080-801Antibody conjugated to R-Phycoerythrin in PBS/EDTA buffer
CD184 (CXCR4)-PE-VIO770Miltenyi Biotec / MACS#130-103-798Monoclonal, Isotype recombinant human IgG1, conjugated
CD309 (VEGFR-2/KDR)-APCMiltenyi Biotec / MACS#130-093-601Antibody conjugated to R-Phycoerythrin in PBS/EDTA buffer
CD34-FITCMiltenyi Biotec / MACS#130-081-001The monoclonal antibody clone AC136 detecs a class III epitope of the CD34
CD45- VioBlueMiltenyi Biotec / MACS#130-092-880Monoclonal CD45 Antibody, human conjugated
Conical TubesThermo SCIENTIFIC#33965115ml conical centrifuge tubes
Cytometry TubesFALCON Corning Brand#3520525 mL Polystyrene Round-Bottom Tube. 12x75 style. Sterile.
EDTABIO-RAD#161-0729Heavy metals, (as Pb) <10ppm, Fe<0.01%, As<1ppm, Insolubles<0.005%
Improved NeubauerWithout brandWithout catalog numberHemocytometer for cell counting. (range 0.1000mm, 0.0025mm2)
K2 EDTA Blood Collection TubesBD Vacutainer#367863Lilac plastic vacutainer tube (K2E) 10.8mg, 6 mL.
LymphoprepStemcell Technologies01-63-12-002-ASterile and checked on the presence of endotoxins. Density: 1.077±0.001g/mL
ParaformaldehydeSIGMA-ALDRICH#SZBF0920VFixation of biological samples, (powder, 95%)
Pipette Transfer 1,3mLCRM GlobePF1016, PF1015The transfer pipette is a tool that facilitates liquid transfer with greater accuracy.
Test TubesKIMBLE CHASE45060 13100Heat-resistant test tubes. SIZE/CAP 13 x 100 mm

References

  1. Serrano-Hernando, F. J., Martín-Conejero, A. Peripheral artery disease: Pathophysiology, diagnosis and treatment. Revista Española de Cardiología. 60 (9), 969-982 (2007).
  2. Agarwal, S., et al. Burden of re-admis....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Flow CytometryDensity Gradient CentrifugationEndothelial DysfunctionLimb Amputation PredictionRutherford ClassificationBrachial Artery FMDVascular Obstruction Blood Collection